A Massachusetts researcher received a $130,000 grant to continue his non-epileptic seizure research.

The funding will help Benjamin Tolchin, a clinical neurophysiology fellow at the Brigham and Women's Hospital in Massachusetts, to continue his investigation into psychogenic non-epileptic seizures through the Practice Research Training Fellowship, cosponsored by the American Academy of Neurology and the American Brain Foundation.

"Currently, there are proven, effective therapies for treating PNES, yet the majority of patients with PNES do not complete these treatments and continue to have non-epileptic seizures many years after they are diagnosed," Tolchin said. "These seizures are common, disabling and dangerous for the patients, and expensive for the health care system. This study endeavors to identify new ways to increase the number of patients who successfully complete therapy to eliminate their non-epileptic seizures."

The two-year award will consist of an annual salary of $55,000 plus $10,000 per year for tuition to support formal education in clinical research methodology. Clinical research is the fundamental transition stage between discovery and treatment and provides the scientific basis for all forms of care, addresses patient and caregiver needs and is the backbone for drug development and cost-effectiveness studies needed to improve lives. Fellowships provide recipients with up to three years of "protected time," with salary that allows them to continue important research projects.

"I feel enormously honored to receive the Practice Research Training Fellowship. I feel very strongly that patients with PNES are in many ways underserved by the health care system, and often do not receive the best possible care," Tolchin said. "I think that this award is a recognition that better treatment and more research are needed for PNES, and I very much hope that I can contribute meaningfully to that need. I am so grateful for the opportunity to focus my time and efforts on improving the quality of care for these patients."